Respiratory Assist Devices Market Report (2022 to 2030) – Phillips Healthcare N.V., Medtronic plc, GE Healthcare, Resmed, Inc., Rotech Healthcare, Inc. and Teleflex Incorporated

Pune, Dec. 12, 2022 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global respiratory assist devices market is expected to clock US$ 17.91 billion by 2030 and to grow at a CAGR of 6.75% during the forecast period. Rising demand from homecare settings is increasing the market revenue. This exclusive information is published by Growth Plus Reports in its report titled “Respiratory Assist Devices Market – Global Outlook & Forecast 2022-2030”

The global respiratory assist devices market has been analyzed from three perspectives: by product, indication, and region.

The most recent development influencing market is the soaring demand for respiratory assist devices in home healthcare settings. The aging population, growing healthcare costs, and growing public awareness of hospital-acquired infections are driving the expansion of home healthcare. Therefore, the market will benefit in the near future from the demand for respiratory assistance equipment in home healthcare. The development of telehealth platforms is also vital in the market’s expansion.

Get a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/respiratory-assist-devices-market/8012

Excerpts from ‘by Product’ 

Based on product types, the global respiratory assist devices market is bifurcated into:

• Monitoring
• Therapeutic Devices

Therapeutic devices have dominated the market. Therapeutic devices segment is classified into ventilators, inhalers, and nebulizers. Inhalers held the dominating position. The consistently growing prevalence of COPD and asthma conditions influences the segment growth. The monitoring devices segment is further divided into pulse oximeters and capnography devices. Between these, pulse oximeters have higher demand, which was further aggravated during the COVID-19 pandemic. The demand for capnography devices in the monitoring segment have significantly increased after the pandemic as people opt for monitoring devices that save them from sudden situations.      

Excerpts from ‘by Indication’

Based on indications, the global respiratory assist devices market is segmented into:

• Asthma
• Chronic Obstructive Pulmonary Diseases
• Chronic Bronchitis
• Pleural Effusion
• Others

COPD currently occupies the largest revenue share. The rising prevalence of the disease is the major factor influencing segment growth. Moreover, market players are increasing their focus on introducing technologically advanced products, such as Pulmonx introduced the Zephyr® Endobrachial Valve System (2018). The device improves lung function, exercise tolerance, and quality of life of patients suffering from COPD or emphysema.

Excerpts from ‘By Region’

Regionally, the global respiratory assist devices market has been segmented into:

• North America
• Europe
• Asia Pacific
• Rest of the world

North America currently has the majority of the market share. The presence of advanced healthcare in this region is the key factor influencing the market growth. The growth of the respiratory assist devices market in the region will also be aided by favorable reimbursement policies. The European market is influenced by factors such as well-established healthcare infrastructure in the region. Support of European government in research and development further facilitates market growth. The Asia Pacific respiratory assist devices market is influenced by factors such as an increasing patient pool with respiratory diseases. Furthermore, countries such as India and China are setting new respiratory assisted devices market trends. 

Get your Customized Research Report: https://growthplusreports.com/inquiry/customization/respiratory-assist-devices-market/8012

Excerpts from ‘Competitive Landscape’

The prominent players operating in the global respiratory assist devices market are:

• Phillips Healthcare N.V.
• GE Healthcare
• Drägerwerk AG & Co. KGaA.
• Hamilton Medical
• Medtronic plc
• Masimo Corporation
• Getinge AB
• Nihon Kohden Corporation
• Resmed, Inc.
• Adapthealth, LLC.
• Rotech Healthcare, Inc.
• Vyaire Medical AG
• Teleflex Incorporated

Table of Content

1. INTRODUCTION
   1. Market Ecosystem 
   2. Timeline Under Consideration
      1. Historical Years – 2020 
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1.    Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions       
3. PREMIUM INSIGHTS
   1. Current Market Trend (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2021) 
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints
   3. Opportunities
5. GLOBAL RESPIRATORY ASSIST DEVICES – ANALYSIS & FORECAST, BY PRODUCT 
   1. Monitoring Devices 
      1. Pulse Oximeters
      2. Capnography Devices
   2. Therapeutic Devices
      1. Ventilators
      2. Inhalers
      3. Nebulizers
6. GLOBAL RESPIRATORY ASSIST DEVICES – ANALYSIS & FORECAST, BY INDICATION 
   1. Asthma 
   2. Chronic Obstructive Pulmonary Diseases (COPD)
   3. Chronic Bronchitis 
   4. Pleural Effusion
   5. Others

TOC Continued….

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Purchase this Report (Price 5950 USD for a Single-User License) – https://growthplusreports.com/checkout?_token=psa188ICrQE941xb8Fb2bKYhAk5ln8MujWH2u4h2&report_id=8012&license=Single

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.